Company Filing History:
1 out of 832,843 Years Active: 1998
Title: Ruediger Von Baehr: Innovator in Monoclonal Antibodies
Introduction
Ruediger Von Baehr is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. His work focuses on addressing critical health challenges, including those posed by the human immunodeficiency virus (HIV).
Latest Patents
Ruediger Von Baehr holds a patent for "Human monoclonal anti-HIV-I-antibodies." This invention is directed to human monoclonal antibodies that are specific for the gp41 envelope protein of HIV-1. The patent specifically discloses human monoclonal antibodies produced by cell lines 3D6, 24G3, and 25C2, each with their respective ECACC Accession Numbers.
Career Highlights
Throughout his career, Ruediger has demonstrated a commitment to advancing medical science through innovative research. His work has been instrumental in the development of therapeutic solutions for HIV, showcasing his expertise in immunology and antibody engineering.
Collaborations
Ruediger has collaborated with esteemed colleagues such as Hermann W Katinger and Alois A Jungbauer. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Ruediger Von Baehr is a distinguished inventor whose work in monoclonal antibodies has the potential to make a significant impact on public health. His dedication to innovation continues to inspire advancements in the fight against HIV.